Time to intracranial hemorrhage (ICH), gastrointestinal bleeding (GIB) and ischemic stroke (IS) was analyzed using competing risk regression, accounting for death as competing risk. Subgroup analysis was performed to detect heterogeneity of effect across mild and moderate thrombocytopenia. Secondary ...
Paradoxical Thromboembolic Ischemic Stroke and Pulmonary Embolism after Uterine Fibroid EmbolizationMatthew Boyko MD aEric Herget MD bYouri Kaitoukov MD bPhilippe Couillard MD a cJournal of Vascular and Interventional Radiology
Additionally, the risk of the composite outcome of thromboembolic complication, hemorrhagic complication or vascular death seems to be notably higher in CSDH patients than in patients with ischemic stroke (19% vs. 2.9–4.1%[17]). A likely reason for the discrepancy in the frequency of ...
Association between ischemic stroke and iron-deficiency anemia: a population-based study. PLoS One. 2013;8(12):e82952. Article PubMed PubMed Central Google Scholar Kuo KL, Hung SC, Tseng WC, et al. Association of anemia and iron parameters with mortality among patients undergoing prevalent ...
Event rates for ischemic stroke and ischemic stroke/systemic embolism were explored. The overall ischemic stroke rate was 3.20 per 100 person-years ('formal rate assessment'). For patients with a CHA2DS2-VASc score of 1 the ischemic stroke rate was 0.97 when using a 'formal rate assessment'...
In addition, we restricted the primary outcome of thromboembolism to ischemic stroke and found a similar association as the main analysis (adjusted HR, 0.73; 95% CI, 0.58-0.90; P = .004). Further, we matched patients with POAF by the components of the CHA2DS2-VASc-score (ie, ...
Alternatively, fingolimod, an immunomodulating agent being tried for COVID-19, may reduce reperfusion injury and improve outcomes in patients suffering from acute ischemic stroke (42). Hydroxychloroquine, recently receiving Emergency Use Authorization from the U.S. Food and Drug Administration for ...
The majority of patients with nonvalvular atrial fibrillation (AF) will require anticoagulation therapy for reducing the risk of stroke, the most devastating complication of AF. Although traditionally vitamin K antagonists have been used for this purpose, they have important limitations that interfere wi...
(n = 270; PV,n = 77) or ischemic stroke (n = 327; PV,n = 107) [42]. Treatment included antithrombotic therapy (aspirin, 85% of patients) and cytoreductive drugs (hydroxyurea, 78% of patients). The composite incidence of recurrent TIA and ischemic stroke, acute ...
· Maha Coucha2 · Mohammed Abdelsaid1,3 Received: 27 June 2024 / Revised: 9 August 2024 / Accepted: 26 September 2024 © The Author(s) 2024 Abstract COVID-19 increases the risk for acute ischemic stroke, yet the molecular mechanisms are unclear and remain unresolved medical ...